Clinical Research

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions
According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.
Copper-based PSMA radiotracer shines in clinical trial
The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics.
Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
M-TEER still beneficial for high-risk patients with smaller mitral valve areas
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
Researchers receive $3.2M in federal funding to test new heart pump for children
The device, currently just a prototype, could be the first of its kind to gain FDA approval.

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

Copper-based radiotracer excels at PSMA imaging

Copper-based PSMA radiotracer shines in clinical trial

The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.

Choon-Sik Jhun, MS, PhD, from Penn State

Researchers receive $3.2M in federal funding to test new heart pump for children

The device, currently just a prototype, could be the first of its kind to gain FDA approval.

Neuralink users reveal power to move robotic arms, play video games with their minds

The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.

Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology) and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, discusses the ATHENS-HF Trial, a first-in-man study of a chronically-adjustbable, bi-atrial pressure sensing inter-atrial shunt from Adona Medical.

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial

Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Beta-blockers do not benefit heart attack patients with a normal LVEF

The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.